Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDG-7500 PK in Renal Impairment
NCT07034768Phase 1Completed
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of edg-7500 in hypertrophic cardiomyopathy (HCM). Primary endpoints: Area under the curve from time zero to last quantifiable concentration, Area under the curve from time zero to extrapolated infinite time and 4 more. Started Jul 2025; status: completed.
02
Drugs
edg-7500
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT07034768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07034768.